Trial intelligence / Profile preview

Phase II dose-ranging study of HR18042 for pain after impacted tooth extraction

ChiCTR2000040954Phase 2Recruiting

Sponsor
West China Hospital of Stomatology, Sichuan University
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of HR18042 in acute postoperative pain (5 arms), sponsored by West China Hospital of Stomatology, Sichuan University. Primary endpoint: Sum of Pain Intensity Difference. Started Aug 2020; status: recruiting.

02

Drugs

HR18042
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on ChiCTR2000040954.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040954.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call